V CompBrief BY VELARION

Independent Director · Intra-Cellular Therapies, Inc. (ITCI)

E. Rene Salas director compensation at Intra-Cellular (FY2023): $461K

Fiscal year 2023 director compensation for E. Rene Salas at Intra-Cellular Therapies, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2024 (DEF 14A). Open the filing on EDGAR.

Free

Get E. Rene Salas’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track E. Rene Salas and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Intra-Cellular Therapies Director Compensation Table · the one fiscal year held
In US dollars, as Intra-Cellular Therapies reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2023$61,357$99,959$299,985—$461,301

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Intra-Cellular Therapies, Inc. DEF 14A filed April 29, 2024, accession 0001628280-24-018986, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Intra-Cellular Therapies, Inc. filed document, accession 0001628280-24-018986. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

Get the Intra-Cellular Therapies Board Governance Report

$461,301 E. Rene Salas, FY2023 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2024 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2023

Intra-Cellular Therapies pays directors a $50,000 cash retainer and $675,000 in RSUs/Options.

Committees

FY2023 · as the proxy prints them

Audit

The rest of the Intra-Cellular Therapies board

FY2023 · as the company reported each
DirectorRoleFY2023 total
Joel S. MarcusIndependent Director$473,337
Robert L. Van NostrandLead Independent Director$507,583
Rory B. RiggsIndependent Director$470,507
Sharon MatesChair of the Board—

The full Intra-Cellular Therapies compensation record

free company brief
Intra-Cellular Therapies, Inc. (ITCI) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within Intra-Cellular Therapies's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Intra-Cellular Therapies proxy · each links to its own free brief

Order ITCI

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report